Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more




  • The Broken Heart: It CAN Be Mended

    The authors advocate that cardiovascular magnetic resonance imaging using specific criteria may be useful as a diagnostic tool for patients with stress cardiomyopathy at the time of acute clinical presentation.
  • Ticagrelor Tablets (Brilinta™)

    A third oral antiplatelet inhibitor has been approved by the FDA to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). Ticagrelor is an adenosine diphosphate receptor P2Y12 inhibitor similar to clopidogrel and prasugrel. It is marketed by AstraZeneca as Brilinta.
  • Something's Fishy — DHA and Prostate Cancer

    In a shocking series of findings, this well-done prospective study showed that in men older than age 55 years a higher proportion of serum omega-3 fatty acids, specifically DHA, actually may increase the risk for high-grade prostate cancer.
  • Non-specific Factors Come to the Fore in Study of Biofield Therapy

    This blinded, randomized, controlled trial found that a biofield therapy and a mock treatment did not differ in their effectiveness in relieving cancer-related fatigue, although they both were significantly better than control. The biofield therapy did lead to significantly greater cortisol variability, which is associated with fatigue.
  • No Preventive Manual — Lymphedema Related to Breast Cancer

    In a prospective study of women with breast cancer who had undergone axillary node dissection, use of manual lymphatic drainage techniques over 5 months provided no additional preventive benefit with respect to development of arm lymphedema over general preventive lifestyle measures and individualized exercise therapy.
  • Sweet! Chocolate for Mind AND Body

    The study authors reviewed observational data on chocolate consumption and the risk of cardiometabolic disease, and found strong evidence of a protective effect. The wide variety of methods employed across studies, among other issues, make cause and effect assumptions premature, though they do fall in line with previous data suggesting chocolate's health benefits.
  • Update on Current Management of Atrial Fibrillation

    Atrial fibrillation (AF) is an irregular, disorganized, electrical activity of the atria.1 It is characterized by uncoordinated atrial activity that leads to inefficient atrial contraction and impaired ventricular filling, which leads to hemodynamic and mechanical functional impairments.
  • Sleep-Disordered Breathing is a Risk Factor for Dementia

    Sleep-disordered breathing is a significant risk factor for cognitive decline and continuous positive airway pressure (CPAP) therapy may prevent or slow this process.
  • New Guidelines for the Management of Extracranial Carotid Arterial Disease

    Duplex ultrasonography should be used in asymptomatic patients with known or suspected carotid arterial stenosis and should be considered for use in asymptomatic patients who have symptomatic peripheral arterial disease, coronary artery disease, or an atherosclerotic aortic aneurysm, and even in the asymptomatic patients who simply are at high cardiovascular risk.
  • Indacaterol Inhalation Powder (Arcapta™ Neohaler)

    An ultra long-acting, orally-inhaled beta2-adrenergic agonist (LABA) has been approved for the treatment of chronic obstructive pulmonary disease (COPD). Indacaterol is formulated as a dry powder and is the first beta2-agonist to be dosed once-daily. It is marketed by Novartis as Arcapta™.